
(1) Non-GAAP adjusted net loss, non-GAAP adjusted net loss attributable to common stockholders, and non-GAAP adjusted net loss per diluted common share are non-GAAP measures. See page 4 for reconciliations of these non-GAAP financial measures to the most comparable GAAP financial measures. | ||
March 31, 2026 | December 31, 2025 | ||
(unaudited) | (audited) | ||
Assets: | |||
Current assets: | |||
Cash and cash equivalents | $95,092 | $67,499 | |
Investments in preferred equity, at fair value | 50,510 | — | |
Prepaid expenses | 2,590 | 2,708 | |
Other current assets | 2,787 | 1,569 | |
Total current assets | 150,979 | 71,776 | |
Digital assets, at fair value | 929,396 | 668,486 | |
Property and equipment, net | 872 | 778 | |
Intangible assets, net | 14,994 | 355 | |
Right-of-use lease assets | 3,932 | 4,037 | |
Other non-current assets | 96 | 95 | |
Total assets | $1,100,269 | $745,527 | |
Liabilities: | |||
Current liabilities: | |||
Compensation and benefits payable | $3,667 | $164 | |
Accounts payable and other liabilities | 4,881 | 8,560 | |
Dividends payable | 4,647 | 2,053 | |
Total current liabilities | 13,195 | 10,777 | |
Long-term notes payable, at fair value | 9,701 | — | |
Operating lease liabilities | 3,416 | 3,512 | |
Total liabilities | 26,312 | 14,289 | |
Mezzanine equity: | |||
Variable Rate Series A Preferred Stock, $0.001 par value; 20,000,000 shares authorized, 4,373,194 and 2,012,729 shares issued and outstanding, $437.3 million and $201.3 million redemption value and liquidation preference as of March 31, 2026 and December 31, 2025, respectively | 359,174 | 148,802 | |
Total mezzanine equity | 359,174 | 148,802 | |
Stockholders’ equity: | |||
Class A common stock, $0.001 par value; 22,200,000,000 shares authorized, 59,286,628 and 34,936,745 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 59 | 699 | |
Class B common stock, $0.001 par value; 1,050,000,000 shares authorized, 9,872,157 and 9,776,540 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 10 | 196 | |
Additional paid-in capital | 1,468,128 | 1,055,595 | |
Accumulated deficit | (753,414) | (474,054) | |
Total stockholders’ equity | 714,783 | 582,436 | |
Total liabilities, mezzanine equity, and stockholders' equity | $1,100,269 | $745,527 |
Successor | Predecessor | |||
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | |||
Revenues: | ||||
Investment advisory fees | $1,347 | $1,416 | ||
Medical device revenues | 1,370 | — | ||
Other revenue | 43 | 7 | ||
Total revenues | 2,760 | 1,423 | ||
Operating expenses: | ||||
Fund management and administration | 1,424 | 1,411 | ||
Employee compensation and benefits | 13,053 | 2,066 | ||
General and administrative expense | 5,938 | 1,906 | ||
Marketing and advertising | 116 | 61 | ||
Depreciation and amortization | 90 | 52 | ||
Total operating expenses | 20,621 | 5,496 | ||
Investment gains/(losses): | ||||
Net unrealized loss on digital assets, at fair value | (295,778) | — | ||
Net unrealized gain on investments in preferred equity, at fair value | 490 | — | ||
Total investment gains/(losses), net | (295,288) | — | ||
Net operating loss | (313,149) | (4,073) | ||
Other income/(expense): | ||||
Other income | 526 | 324 | ||
Interest expense on long-term notes payable, at fair value | (242) | — | ||
Change in fair value on long-term notes payable, at fair value | (2,165) | — | ||
Loss on extinguishment of debt | (8,461) | — | ||
Loss on change in fair value of bitcoin held as collateral under Coinbase Loan | (2,594) | — | ||
Transaction costs | (6,525) | — | ||
Bargain purchase gain | 66,704 | — | ||
Total other income, net | 47,243 | 324 | ||
Net loss before income taxes | (265,906) | (3,749) | ||
Income tax benefit/(expense) | — | — | ||
Net loss | $(265,906) | $(3,749) | ||
Dividends on preferred stock | (13,454) | — | ||
Net loss attributable to common stockholders | $(279,360) | $(3,749) | ||
Weighted average number of common shares outstanding: | ||||
Basic (1) | 61,630,003 | 2,275,940 | ||
Diluted (1) | 61,630,003 | 2,275,940 | ||
Net loss per common share: | ||||
Basic (1) | $(4.53) | $(1.65) | ||
Diluted (1) | $(4.53) | $(1.65) |
Successor | Predecessor | |||
Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 | |||
Net loss | $(265,906) | $(3,749) | ||
Share-based compensation expense | 6,529 | — | ||
Depreciation and amortization | 90 | 52 | ||
Change in fair value on long-term notes payable, at fair value | 2,165 | — | ||
Loss on extinguishment of debt | 8,461 | — | ||
Loss on change in fair value of bitcoin held as collateral under Coinbase Loan | 2,594 | — | ||
Transaction costs | 6,525 | — | ||
Bargain purchase gain | (66,704) | — | ||
Non-GAAP adjusted net income (loss) | $(306,246) | $(3,697) | ||
Dividends on preferred stock | (13,454) | — | ||
Non-GAAP adjusted net loss attributable to common stockholders | $(319,700) | $(3,697) | ||
Weighted average number of diluted common shares outstanding | 61,630,003 | 2,275,940 | ||
Net loss per diluted common share | $(4.53) | $(1.65) | ||
Non-GAAP adjusted net loss per diluted common share | $(5.19) | $(1.62) |